Market and Impact

The Problem:

• Sleep apnea affects over 30 million adults in the US, yet approximately 80% remain undiagnosed
• Traditional sleep lab testing is expensive, uncomfortable, and difficult to access
• Delayed diagnosis increases risk of cardiovascular disease and other serious health complications

The Market Opportunity:

• Rapid growth in at-home, technology-enabled sleep diagnostics
• US sleep apnea diagnostics and treatment market valued at $7.5B, projected to reach $13B by 2030

Why It Matters:

• Increases access to early diagnosis
• Reduces long-term health risks of untreated sleep apnea
• Reduces strain on sleep labs and healthcare systems
• Improves quality of life through early intervention

Market Strategy:

• Direct-to-consumer access for individuals seeking at-home screening
• Clinical distribution through sleep clinics and hospitals
• Research partnerships to support validation and credibility

Pricing:

• Starter kits will be sold at $79-$129 per unit
• Replacement sensor patches will be sold at $10-$15 per unit
• The app subscription will be priced at $5-$15 per month

Startup Costs:

• Product & Sensors: Prototyping, materials, manufacturing
• Software: App development, AI analytics
• Clinical & Regulatory: Pilot studies, FDA preparation
• Operations: Assembly, patents
• Estimated funding needed: $485K for launch